ARCHIVES

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses

June 8, 1979

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990

March 8, 1985

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009